DE68919266D1 - Immunstimulierende Guaninderivate, Zusammenstellungen und Verfahren. - Google Patents

Immunstimulierende Guaninderivate, Zusammenstellungen und Verfahren.

Info

Publication number
DE68919266D1
DE68919266D1 DE68919266T DE68919266T DE68919266D1 DE 68919266 D1 DE68919266 D1 DE 68919266D1 DE 68919266 T DE68919266 T DE 68919266T DE 68919266 T DE68919266 T DE 68919266T DE 68919266 D1 DE68919266 D1 DE 68919266D1
Authority
DE
Germany
Prior art keywords
compositions
stimulating
immune
processes
guanine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68919266T
Other languages
English (en)
Other versions
DE68919266T2 (de
Inventor
Michael Dr Goodman
Robert Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Publication of DE68919266D1 publication Critical patent/DE68919266D1/de
Application granted granted Critical
Publication of DE68919266T2 publication Critical patent/DE68919266T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE68919266T 1988-05-05 1989-05-04 Immunstimulierende Guaninderivate, Zusammenstellungen und Verfahren. Expired - Fee Related DE68919266T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/190,694 US5093318A (en) 1983-11-01 1988-05-05 Immunostimulating guanosine derivatives and their pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DE68919266D1 true DE68919266D1 (de) 1994-12-15
DE68919266T2 DE68919266T2 (de) 1995-06-01

Family

ID=22702383

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68919266T Expired - Fee Related DE68919266T2 (de) 1988-05-05 1989-05-04 Immunstimulierende Guaninderivate, Zusammenstellungen und Verfahren.

Country Status (12)

Country Link
US (1) US5093318A (de)
EP (1) EP0341066B1 (de)
JP (1) JP2790846B2 (de)
AT (1) ATE113957T1 (de)
AU (1) AU619539B2 (de)
CA (1) CA1320196C (de)
DE (1) DE68919266T2 (de)
DK (1) DK170780B1 (de)
ES (1) ES2063125T3 (de)
GR (1) GR3015018T3 (de)
IE (1) IE66321B1 (de)
PT (1) PT90464B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011828A (en) * 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods
US6060459A (en) * 1987-10-28 2000-05-09 Pro-Neuron, Inc. Enhancing blood cell count with oxypurine nucleosides
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
AU5165793A (en) * 1992-10-01 1994-04-26 Mcneilab, Inc. Derivatives of 7,8-disubstituted guanosines
US6727230B1 (en) * 1994-03-25 2004-04-27 Coley Pharmaceutical Group, Inc. Immune stimulation by phosphorothioate oligonucleotide analogs
US5786359A (en) * 1994-05-27 1998-07-28 The Scripps Research Institute N9 alkyl or aralkyl derivatives of 7, 8-disubstituted guanines
US5382580A (en) * 1994-05-27 1995-01-17 The Scripps Research Institute N9 morpholino derivatives of 7,8-disubstituted guanines
US5441942A (en) * 1994-05-27 1995-08-15 The Scripps Research Institute 2'3'-dideoxy-2',3'-didehydro-7,8-disubstituted guanosines and their immunostimulative effect
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US5773424A (en) * 1994-12-16 1998-06-30 Research Corporation Technologies, Inc. Treatment of toxoplasmosis
US20030100520A1 (en) * 1997-01-21 2003-05-29 Philip Needleman Immunological process and constructs for increasing the hdl cholesterol concentration by dna vaccination
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
AU4244400A (en) * 1999-04-15 2000-11-02 Board Of Regents, The University Of Texas System Ppgpp and pppgpp as immunomodulatory agents
US6949520B1 (en) * 1999-09-27 2005-09-27 Coley Pharmaceutical Group, Inc. Methods related to immunostimulatory nucleic acid-induced interferon
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US20010044416A1 (en) * 2000-01-20 2001-11-22 Mccluskie Michael J. Immunostimulatory nucleic acids for inducing a Th2 immune response
US7585847B2 (en) * 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ES2385931T3 (es) 2000-07-07 2012-08-03 Spectrum Pharmaceuticals, Inc. MÉTODOS PARA EL TRATAMIENTO DE NEUROPATíA PERIFÉRICA INDUCIDA POR UNA ENFERMEDAD Y AFECCIONES RELACIONADAS.
US20030138769A1 (en) * 2000-08-16 2003-07-24 Birkett Ashley J. Immunogenic HBc chimer particles having enhanced stability
ATE398175T1 (de) * 2000-12-08 2008-07-15 Coley Pharmaceuticals Gmbh Cpg-artige nukleinsäuren und verfahren zu ihrer verwendung
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US7361352B2 (en) * 2001-08-15 2008-04-22 Acambis, Inc. Influenza immunogen and vaccine
US20030175863A1 (en) * 2001-08-15 2003-09-18 Birkett Ashley J. Influenza immunogen and vaccine
US20030185858A1 (en) * 2001-08-15 2003-10-02 Birkett Ashley J. Immunogenic HBc chimer particles stabilized with an N-terminal cysteine
US7351413B2 (en) * 2002-02-21 2008-04-01 Lorantis, Limited Stabilized HBc chimer particles as immunogens for chronic hepatitis
WO2004087203A2 (en) * 2003-04-02 2004-10-14 Coley Pharmaceutical Group, Ltd. Immunostimulatory nucleic acid oil-in-water formulations for topical application
CN101268092B (zh) * 2005-09-22 2012-07-04 弗·哈夫曼-拉罗切有限公司 核苷的选择性o-酰基化
HUE025149T2 (hu) * 2007-08-02 2016-01-28 Biondvax Pharmaceuticals Ltd Multimer multiepitóp influenza vakcinák
EP2722056A1 (de) 2007-12-03 2014-04-23 President and Fellows of Harvard College CT062, ein Chlamydia-Antigene
CN102239253A (zh) 2008-12-03 2011-11-09 普罗蒂亚维仕尼科技有限公司 谷氨酰tRNA合成酶（GtS）片段
WO2011067758A2 (en) 2009-12-02 2011-06-09 Protea Vaccine Technologies Ltd. Immunogenic fragments and multimers from streptococcus pneumoniae proteins
US9303070B2 (en) 2011-02-22 2016-04-05 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
EP2833900B1 (de) 2012-04-01 2018-09-19 Technion Research & Development Foundation Limited Extrazelluläre matrix-metalloproteasen-induktor (emmprin)-peptide und bindende antikörper
US10426828B2 (en) 2014-04-03 2019-10-01 Biondvax Pharmaceuticals Ltd. Compositions of multimeric-multiepitope influenza polypeptides and their production
BR112020023866A2 (pt) 2018-05-25 2021-04-06 Primmune Therapeutics, Inc. Agonistas de tlr7

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948730A (en) * 1982-11-09 1990-08-14 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4539205A (en) * 1982-11-09 1985-09-03 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4643992A (en) * 1982-11-09 1987-02-17 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5011828A (en) * 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods

Also Published As

Publication number Publication date
CA1320196C (en) 1993-07-13
GR3015018T3 (en) 1995-05-31
DK217289D0 (da) 1989-05-03
ES2063125T3 (es) 1995-01-01
PT90464B (pt) 1994-12-30
IE891463L (en) 1989-11-05
EP0341066A3 (en) 1990-05-30
JP2790846B2 (ja) 1998-08-27
EP0341066A2 (de) 1989-11-08
JPH0256496A (ja) 1990-02-26
DK170780B1 (da) 1996-01-15
AU3399989A (en) 1989-11-09
IE66321B1 (en) 1995-12-27
DK217289A (da) 1989-11-06
US5093318A (en) 1992-03-03
DE68919266T2 (de) 1995-06-01
AU619539B2 (en) 1992-01-30
ATE113957T1 (de) 1994-11-15
EP0341066B1 (de) 1994-11-09
PT90464A (pt) 1989-11-30

Similar Documents

Publication Publication Date Title
DE68919266D1 (de) Immunstimulierende Guaninderivate, Zusammenstellungen und Verfahren.
DE68917012D1 (de) Immunstimulierende Guaninderivate, Zusammenstellungen und Verfahren.
LV5624A3 (lv) Panemiens 5'-dezoksi-5-fluorcitidina atvasinajumu iegusanai
PT88401A (pt) Improvements relating to smoking articles
LV5264A3 (lv) Panemiens guanina atvasinajumu vai to farmaceitiski pielietojamu skabju-aditivo saju iegusanai
FI900412A0 (fi) Antiviral eller antibakteriell foerening och foerfarande foer anvaendning daerav.
ATE133858T1 (de) Verwendung von monoolein bei der behandlung der periodontal- tasche
DE69110854D1 (de) Antivirusderivate von (Phosphonmethoxy)Methoxy Purin/Pyrimidin.
DK209187D0 (da) Anvendelse af adenosin-derivater til behandling af demens
KR880701730A (ko) 아데노신의 복소방향족 유도체
ATE67203T1 (de) 9-deazaquanine.
NO178497C (no) Fremgangsmåte for fremstilling av 9-substituerte guaninderivater og mellomprodukter for anvendelse i fremgangsmåten
DE68927651D1 (de) Derivate von Fluorphosphonat-Nukleotiden
NZ233781A (en) (cyclic)phosphonyl-substituted guanine or adenine derivatives and pharmaceutical compositions
IT1234230B (it) Solfonammidi di benzilidene canfora derivanti da amminoacidi e loro impiego in cosmesi particolarmente come filtri solari
GR3023611T3 (en) Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections
ATE36718T1 (de) Glykosaminoglykane verwendbar in kosmetologie.
NO930160D0 (no) Antivirale fosfono-alken-derivater av puriner
IT8722204A0 (it) Dispositivo per la rotazione di pendagli per ornamenti personali

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee